233
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Enzymatic synthesis and evaluation of new novel ω-pentadecalactone polymers for the production of biodegradable microspheres

, , , , &
Pages 213-226 | Received 22 Jun 2005, Accepted 20 Sep 2005, Published online: 08 Oct 2008

References

  • Benoit MA, Baras B, Gillbard J. Preparation and characterization of protein-loaded poly(ϵ-caprolactone) microparticles for oral vaccine delivery. International Journal of Pharmaceutics 1999; 184: 73–84
  • Blanco MD, Bernardo MV, Sastre RL, Olmo R, Muñiz E, Teijón JM. Preparation of bupivacaine-loaded poly(ϵ-caprolactone) microspheres by spray drying: Drug release studies and biocompatibility. European Journal of Pharmaceutics and Biopharmaceutics 2003; 55: 229–236
  • Cha Y, Pitt CG. A one week subdermal delivery system for L-methadone based on biodegradable microcapsules. Journal of Controlled Release 1988; 7: 69–78
  • Chandy T, Wilson RF, Rao HR, Das G. Changes in cisplatin delivery due to surface-coated poly(lactic acid)-poly(ϵ-caprolactone) microspheres. Journal of Biomaterial Applications 2002; 16: 275–291
  • Clarke N, O'connor K, Ramtoola Z. Influence of formulation variables on the morphology of biodegradable microparticles prepared by spray drying. Drug Development and Industrial Pharmacy 1998; 24: 169–174
  • Conti B, Pavanetto F, Genta I. Use of polylactic acid for the preparation of microparticulate drug delivery systems. Journal of Microencapsulation 1992; 9: 153–166
  • Das GS, Rao GH, Wilson RF, Chandy T. Colchicine encapsulation within poly(ethylene glycol)-coated poly(lactic acid)/poly(ϵ-caprolactone) microspheres-controlled release studies. Drug Delivery 2000; 7: 129–138
  • Engelberg I, Kohn J. Physico-mechanical properties of degradable polymers used in medical applications: A comparative study. Biomaterials 1991; 12: 292–303
  • Flandroy P, Grandfils C, Jerome R. Clinical applications of microspheres in embolization and chemoembolization: Comprehensive review and perspectives. Pharmaceutical particulate carriers: Therapeutic applications, A Rolland. Marcel Dekker, New York 1993; 321–366
  • Flandroy P, Grandfils C, Daenen B, Snaps F, Dondelinger RF, Jerome R, Bassleer R, Heinen E. In vivo behaviour of poly(D,L)-lactide microspheres designed for chemoembolization. Journal of Controlled Release 1997; 44: 153–170
  • Giunchedi P, Conte U. Spray-drying as a preparation method of microparticulate drug delivery systems: An overview. STP Pharma Sciences 1995; 5: 276–290
  • Guzman M, Molpeceres J, Garcia F, Aberturas MR. Preparation, characterization and in vitro drug release of poly-epsilon-caprolactone and hydroxypropyl methylcellulose phthalate ketoprofen loaded microspheres. Journal of Microencapsulation 1996; 13: 25–39
  • Hillery AM, Lloyd AW, Swarbrick J. Drug delivery and targeting for pharmacists and pharmaceutical scientists. Taylor & Francis, London 2001
  • Jain JA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000; 21: 2475–2490
  • Jameela SR, Suma N, Jayakrishana A. Protein release from poly(ϵ-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: A comparative study. Journal of Biomaterial Science Polymer 1997; 8: 457–466
  • Jeong JC, Lee J, Cho K. Effects of crystalline microstructure on drug release behavior of poly(ϵ-caprolactone) microspheres. Journal of Controlled Release 2003; 92: 249–258
  • Juni K, Ogata J, Nakano M, Ichihara T, Mori K, Akagi M. Preparation and evaluation in vitro and in vivo of poly(lactic acid) microspheres containing doxorubicin. Chemical and Pharmaceutical Bulletin 1985; 33: 313–318
  • Kline BJ, Beckman EJ, Russell AJ. One-step biocatalytic synthesis of linear polyesters with pendant hydroxyl groups. Journal of American Chemical Society 1998; 120: 9475–9480
  • Langer R. Polymeric delivery systems for controlled drug release. Chemical Engineering Communication 1980; 6: 1–48
  • Martini LG, Collett JH, Attwood D. The release of 5-FU from microspheres of poly(ϵ-caprolactone-co-ethyleneoxide). Drug Development and Industrial Pharmacy 2000; 26: 7–12
  • Murillo M, Gamazo C, Goni M, Irache J, Blanco-Prieto M. Development of microparticles prepared by spray-drying as a vaccine delivery system against brucellosis. International Journal of Pharmaceutics 2002; 242: 341–344
  • Namekawa S, Uyama H, Kobayashi S. Enzymatic synthesis of polyesters from lactones, dicarboxylic acid divinyl esters, and glycols through combination of ring-opening polymerization and polycondensation, Biomacromolecules 2000; 1: 335–338
  • Nihant N, Stassen S, Grandfils C, Jerome R, Teyssie P. Microencapsulation by coacervation of poly(lactide-co-glycolide) – II: Encapsulation of a dispersed aqueous phase. Polymer International 1993; 32: 171–176
  • Park TG. Degradation of poly(Dl-lactic acid) microspheres: Effect of molecular weight. Journal of Controlled Release 1994; 30: 161–173
  • Park TG. Degradation of poly(lactic-co-glycolic acid) microspheres: Effect of copolymer composition. Biomaterials 1995; 16: 1123–1130
  • Pitt CG. Poly(ϵ-caprolactone) and its copolymers. Biodegradable polymers as drug delivery systems, M Chasin, R Langer. Marcel Dekker, New York 1997; 71–120
  • Pitt CG, Gratzl MM, Jeffcoat AR, Zweidinger R, Schindler A. Sustained drug delivery systems II: Factors affecting release rates from poly(ϵ-caprolactone) and related biodegradable polyesters. Journal of Pharmaceutical Sciences 1979; 68: 1534–1538
  • Pitt CG, Marks TA, Schindler A. Biodegradable drug delivery systems based on aliphatic polyesters: Application to contraceptives and narcotic antagonists. NIDA Research Monograph 1981; 28: 232–253
  • Rafler G, Jobmann M. Controlled release systems of biodegradable polymers. Pharmaceutical Industry 1994; 56: 565–570
  • Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-ϵ-caprolactone microspheres and nanospheres: An overview. International Journal of Pharmaceutics 2004; 278: 1–23
  • Sondhof AF, Mallapragada S, Booth LC, Heath C, Rosenbusch R, Apley M, Hsu W. Polylactic acid (biodegradable) microspheres for sustained antimicrobial drug release in the equine joint: Preliminary in vivo results. International Journal on the Symposium of the Controlled Release of Bioactive Materials 1998; 25: 651–652
  • Tice TR, Cowsar DR. Biodegradable controlled-release parenteral systems. Pharmaceutical Technology 1984; 11(November)26–34
  • Wang HT, Palmer H, Linhardt RJ, Flanagan DR, Schmitt E. Degradation of poly(ester) microspheres. Biomaterials 1990; 11: 679–685
  • Watts PJ, Davies MC, Melia CD. Microencapsulation using emulsification/solvent evaporation: An overview of techniques and applications. Critical Reviews in Therapeutic Drug Carrier Systems 1990; 7: 235–259
  • Whateley TL. Biodegradable microspheres for controlled drug delivery. Encapsulation and controlled release, DR Karsa, RA Stephenson. The Royal Society of Chemistry, Cambridge 1997; 52–65
  • Youan BBC, Benoit MA, Baras B, Gillbard J. Protein-loaded poly(ϵ-caprolactone) microparticles, optimization of the preparation by (water-in-oil) in-water emulsion solvent evaporation. Journal of Microencapsulation 1999; 16: 587–599

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.